Public Company News
MoonFox Data: JD.com Q3 profits exceeded expectations and the "low prices & supply chain" combo approach showed initial effectiveness
CHENGDU, China, Dec. 12, 2023 /PRNewswire/ -- About us: Aurora Mobile (NASDAQ: JG) established in 2011, is a leading customer engagement and marketing technology service provider inChina. Its business includes notification services, marketing growth, development tools, and data products. As its ...
2023-12-12 15:20
3151
MINISO Group Gives Updates on Increase Plan in Shareholding by Management
GUANGZHOU, China, Dec. 11, 2023 /PRNewswire/ -- MINISO Group Holding Limited (NYSE: MNSO; HKEX: 9896) ("MINISO", "MINISO Group" or the "Company"), a global value retailer offering a variety of trendy lifestyle products featuring IP design, today announced that Mr. Zhang Jingjing, the Company's Ch...
2023-12-12 12:15
2414
Live from ASH 2023 | Ascentage Pharma Presents the First Dataset of Bcl-2 inhibitor Lisaftoclax in Patients with AML, Demonstrating Favorable Efficacy and Safety
SUZHOU, China and ROCKVILLE, Md., Dec. 11, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released the results of lisaftoclax (A...
2023-12-12 09:41
3120
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
NEW YORK, Dec. 11, 2023 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the "Company") announced today that an aggregate of$50,000 has been deposited into the Company's trust account to further extend the period of time the Company has to consummate its business combination by an...
2023-12-12 05:30
2778
Lunit Advances to Stage 2 of Australia's National Breast Cancer Screening Project
* After a successful stage 1, Lunit INSIGHT MMG moves to prospective validation inAustralia's BreastScreen NSW Machine Reading Solution Project SEOUL, South Korea, Dec. 11, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therape...
2023-12-11 22:30
2501
Hollysys to be Acquired by Ascendent Capital Partners for US$26.50 in Cash Per Share
* Hollysys Board has unanimously approved Ascendent's all cash offer at 42% premium to the unaffected price as of23 August 2023 * Agreement marks culmination of formal sale process conducted by Special Committee of independent directors BEIJING, Dec. 11, 2023 /PRNewswire/ -- Hollysys Automati...
2023-12-11 22:10
3784
Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments
SHANGHAI, Dec. 11, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin"),...
2023-12-11 21:00
3111
WiMi Developed Holographic Complex Amplitude Computation and Update Technology
BEIJING, Dec. 11, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that it successfully developed a new technology----"Holographic Complex Amplitude Computation and Updat...
2023-12-11 21:00
2335
HanAll Biopharma's Partner, NurrOn Pharmaceuticals Incorporated Appoints Dr. Almira Chabi, MD, EGMP to Board of Directors
WOBURN, Mass., Dec. 11, 2023 /PRNewswire/ -- HanAll Biopharma's partner NurrOn Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to developing novel, targeted therapeutics for the treatment of Parkinson's disease (PD) and other Nurr1-related human disorders, is pleased to...
2023-12-11 20:00
2385
Mabwell Announces the CDE Approval of Novel Nectin-4 Targeting ADC for Phase III Clinical Trial
SHANGHAI, Dec. 11, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its submission to the Center for Drug Evaluation (CDE) of the National Medical Products Administration for the "A Randomized, Open-label, Controlled, Mu...
2023-12-11 20:00
1837
2023 SABCS | Laekna Reports Afuresertib Phase Ib Breast Cancer Study Results
- A multi-center phase Ib/III study in China and the United States led by ProfessorBinghe Xu, MD, PhD, Academician of the Chinese Academy of Engineering - 70% of the patients enrolled in phase Ib study were previously treated with CDK4/6 inhibitors - Demonstrated a confirmed objecti...
2023-12-11 18:55
1998
Qudian Inc. Reports Third Quarter 2023 Unaudited Financial Results
XIAMEN, China, Dec. 11, 2023 /PRNewswire/ -- Qudian Inc. ("Qudian" or "the Company" or "We") (NYSE: QD), a consumer-oriented technology company, today announced its unaudited financial results for the quarter endedSeptember 30, 2023. Third Quarter 2023 Financial Highlights: * Total revenues w...
2023-12-11 18:00
3728
Live from ASH 2023 | Ascentage Pharma Presents Updated Data from US Study of Olverembatinib, Further Validating Encouraging Efficacy in Patients Resistant to Ponatinib or Asciminib
SUZHOU, China, and ROCKVILLE, Md., Dec. 10, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released updated data from a US study ...
2023-12-11 13:30
1926
Live from ASH 2023 | Ascentage Pharma Releases Encouraging Long-Term Data of Bcl-2 Inhibitor Lisaftoclax in R/R CLL, Including an ORR of 73.3%
SUZHOU, China and ROCKVILLE, Md., Dec. 10, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released the latest efficacy and safety...
2023-12-11 13:14
1906
Live from ASH 2023 | Ascentage Pharma Releases the First Dataset of Bcl-2 Inhibitor Lisaftoclax in Patients with R/R MM, Demonstrating Encouraging ORR and VGPR
SUZHOU, China and ROCKVILLE, Md., Dec. 10, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released the clinical data of lisaftocl...
2023-12-11 12:56
1559
Dizal's Golidocitinib Pivotal Trial Demonstrates Superior and Durable Clinical Benefits for Patients with r/r PTCL in Oral Presentation at 2023 ASH
* Full analysis of multinational pivotal study results of golidocitinib in relapsed or refractory peripheral T-cell lymphoma (r/r PTCL) (JACKPOT8 PART B) simultaneously published inThe Lancet Oncology and presented in oral session at the 65th American Society of Hematology Annual Meeting and Ex...
2023-12-10 18:00
2567
WiMi Announced Augmented Reality Dynamic Image Recognition Based on Deep Convolutional Neural Networks
BEIJING, Dec. 8, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that the deep convolutional neural network(DCNN) was used as the core algorithm for image recognition, a...
2023-12-08 21:00
3079
Lanvin Group Holdings Limited to Hold Annual General Meeting on December 21, 2023
NEW YORK, Dec. 8, 2023 /PRNewswire/ -- Lanvin Group Holdings Limited (NYSE: LANV, the "Company" or "Lanvin Group"), a global luxury fashion group, today announced that it will hold its annual general meeting of the shareholders (the "AGM") virtually through a live webcast and teleconference onDec...
2023-12-08 19:43
4643
President Jokowi Applauds BRI's Empowerment of MSMEs at the UMKM EXPO(RT) BRILIANPRENEUR 2023
JAKARTA, Indonesia, Dec. 8, 2023 /PRNewswire/ -- PT Bank Rakyat Indonesia (BRI) Persero Tbk. (IDX: BBRI)marked its 128th anniversary with the UMKM EXPO(RT) BRILIANPRENEUR 2023, inaugurated by Indonesia's President, Joko Widodo (Jokowi), at theJakarta Convention Center from December 7 to 10. In hi...
2023-12-08 19:42
4775
ChipMOS REPORTS 20.3% YoY INCREASE IN NOVEMBER 2023 REVENUE
HSINCHU, Dec. 8, 2023 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange: 8150 and NASDAQ: IMOS), an industry leading provider of outsourced semiconductor assembly and test services ("OSAT"), today reported a 20.3% year over year increase for i...
2023-12-08 19:00
4688
Week's Top Stories
Most Reposted
Visa Working Capital Index: Asia Pacific CFOs Call for Flexible, Digital Finance Solutions
[Picked up by 308 media titles]
2026-03-24 14:00HOY Unveils a Powerhouse Line-up of Talent for its Bold New Chapter
[Picked up by 306 media titles]
2026-03-20 09:36
MetaOptics progresses on its strategic growth and leadership transition initiatives
[Picked up by 283 media titles]
2026-03-20 08:15ART CENTRAL COMMENCES DISCOVERY-LED ELEVENTH EDITION
[Picked up by 277 media titles]
2026-03-25 16:51
Allianz Partners Australia's 2025 State of Student Healthcare Report Unpacks the Complex Realities of International Students
[Picked up by 275 media titles]
2026-03-19 09:00Most Read
Everbright Environment Announces 2025 Annual Results
2026-03-20 23:14
7757
Ten Pao Group Announces 2025 Annual Results
2026-03-20 23:35
7543
FiEE, Inc. Announces Fourth Quarter and Full-Year 2025 Financial Results
2026-03-21 04:05
7518
U Power Limited Announces Closing of $6.0 Million Public Offering
2026-03-21 02:40
7073